POS5 THE COST-EFFECTIVENESS OF IBANDRONA
POS5 THE COST-EFFECTIVENESS OF IBANDRONATE IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS IN THE US
β
SR Earnshaw; CN Graham; MM Amonkar; CE Barr
π
Article
π
2006
π
John Wiley and Sons
π
English
β 48 KB